BlackRock
WINT

BlackRock’s Windtree Therapeutics Inc WINT Stock Holding History

BlackRock’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-196,091
Closed -$224K – 5189
2017
Q1 		$224K Buy
+196,091
New +$255K ﹤0.01% 4193
2014
Q2 		– Sell
-2
Closed – – 3277
2014
Q1 		$0 Buy
+2
New +$67 ﹤0.01% 3203

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

BlackRock's WINT Position: Q2 2017 in Review

BlackRock sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 196,091 shares — an estimated $224K sold.

BlackRock first reported a position in WINT in Q1 2014 and held it in 2 quarters. The position peaked at $224K in Q1 2017. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • BlackRock reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • BlackRock sold 196,091 Windtree Therapeutics Inc shares in Q2 2017, an estimated $224K.
  • BlackRock first reported a position in Windtree Therapeutics Inc in Q1 2014 and held it in 2 quarters.
  • BlackRock's Windtree Therapeutics Inc position peaked at $224K in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on BlackRock's 13F filing for Q2 2017, filed 10 Aug 2017.